Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experience.

Omar K SiddiqiYuliya Y MintsJohn L BerkLawreen H ConnorsGheorghe DorosDeepa M GopalShivangi KatariaGraham LohrmannAlexandra R PipilasFrederick L Ruberg

Published in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2022)

Diflunisal administration in ATTRwt-CM was associated with improved survival and overall stability in clinical and echocardiographic markers of disease with decrement renal function.

Keyphrases

wild type
early stage
heart failure
free survival
left ventricular
mitral valve
sentinel lymph node
left atrial
radiation therapy
lymph node
ejection fraction
neoadjuvant chemotherapy
replacement therapy